Neuros Medical Raises $1.8 million A Round

CLEVELAND--(Business Wire)--
Neuros Medical, Inc., a medical device company developing innovative
neurostimulation technology for the treatment of chronic pain, announced today a
$1.8 million series A round of investment, led by the North Coast Angel Fund
(NCAF), which was joined in the investment by Glengary LLC, Ohio Tech Angel
Fund, Queen City Angels First Fund III, and individual investors. This round
follows the initial investment made earlier in the year from JumpStart Ventures
and Case Technology Ventures.

The company will utilize the funding to commence product development, expand its
management team, and complete clinical studies.

The company`s initial target is focused on the chronic pain market, including
residual limb pain, chronic post surgical pain, and chronic migraine.

Neuros` technology, created by Drs. Kevin Kilgore and Niloy Bhadra of Case
Western Reserve University`s Department of Biomedical Engineering and
MetroHealth Medical Center, and supported by BioEnterprise, is referred to as
"Nerve Block" and delivers high-frequency stimulation to sensory nerves in the
peripheral nervous system to block chronic pain. The system consists of an
electrode (also known as a lead) placed around a peripheral nerve and powered by
a pace-maker size generator.

"We are very excited to be able to support Neuros by leading this round of
investment," said Claiborne R. Rankin, NCAF`s Managing Director. "We are
impressed with the significant market opportunity and management`s vision for
how to realize the potential of this exciting technology."

Glengary`s Managing Director Steve Haynes added, "Neuros has excellent potential
to change how chronic pain is treated today, which affects millions of patients
in the U.S. We are very optimistic about the company`s direction, leadership and
ability to make this impact."

Neuros Medical`s Chief Executive Officer, Jon J. Snyder, stated, "The completion
of this round of investment, especially in these trying economic times, is a
tribute to our technology`s promise and the support of key funders in Ohio." All
of the entities involved are supported by the State of Ohio`s $1.6 Billion Third
Frontier Program.

About Neuros Medical, Inc.

Neuros Medical, a Cleveland, Ohio based neurostimulation company, is focused on
developing proprietary neurostimulation therapies for unmet needs to patients
worldwide. The company`s patented platform technology, Nerve Block, provides
patients with elimination of chronic pain in a variety of applications including
neuroma/residual limb pain, chronic post surgical pain, and chronic migraine.

Neuros Medical, Inc.
Jon J. Snyder, 440-487-7515
President and CEO
jsnyder@neurosmedical.com

Copyright Business Wire 2009